M 18 (Metoprolol 25 mg)
Pill imprint M 18 has been identified as Metoprolol tartrate 25 mg.
Metoprolol is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; heart attack; angina (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 18
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0018
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0255 | UDL Laboratories Inc |
| 67544-0567 | Prepak Systems Inc (repackager) |
| 55289-0382 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about metoprolol
Consumer resources
- Metoprolol
- Metoprolol succinate extended-release tablets
- Metoprolol (Advanced Reading)
- Metoprolol Intravenous (Advanced Reading)
- Other brands: Metoprolol Tartrate, Metoprolol Succinate ER, Toprol-XL, Lopressor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
